Literature DB >> 1944378

Effects of caffeine and cycloheximide during G2 prophase in control and X-ray-irradiated human lymphocytes.

J Pincheira1, J F López-Sáez.   

Abstract

The effect of caffeine and cycloheximide during the G2 phase on frequency of chromosomal aberrations and G2 duration was studied in control and X-ray-irradiated human lymphocytes in vitro. Caffeine treatments alone increase the frequencies of chromatid breakage and decrease the average G2 duration in control and X-ray-irradiated lymphocytes (40 R). Both caffeine effects are reversed by 0.5 micrograms/ml cycloheximide in combination treatments. Cycloheximide treatments alone prolong G2 duration in control as well as in X-ray-irradiated lymphocytes although no improvement in chromosome repairing by this inhibitor of protein synthesis was observed under the conditions of our experiments. We propose that the cycloheximide effect is associated with a low level of mitotic factors, required for the entrance into mitosis, which is maintained at a higher level in caffeine treatment alone. Finally, G2 delay has generally been associated with certain genome damage. The fact that the caffeine and cycloheximide effects on X-irradiated lymphocytes are also present in control lymphocytes (without X-rays) suggests that control of the G2 duration constitutes one of the mechanisms involved in DNA repair operating during the G2 phase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944378     DOI: 10.1016/0027-5107(91)90216-b

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  A system for mutation measurement in mammalian cells: application to gamma-irradiation.

Authors:  T T Puck; R Johnson; S Rasumussen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation.

Authors:  Wen Deng; Pei Shin Pang; Chi Man Tsang; Pok Man Hau; Yim Ling Yip; Annie L M Cheung; Sai Wah Tsao
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.